Difference in size between circulating tumor and healthy DNA could be turned to an advantage SALT LAKE CITY – The liquid biopsy, a new type of blood test for detecting and monitoring cancer, is a welcome reprieve from typical biopsies. ...
Read More »The Capture and Identification of Circulating DNA and Tumor Cells Is Fueling a Biotech Revolution That Is Longing For Clinical Acceptance
from Genetic Engineering News by Jeffrey S. Buguliskis, Ph.D. The term “biopsy” frequently evokes fear in patients, as the procedure is most often associated with cancer screening. Nevertheless, patient fears about biopsies are not wholly unwarranted and not simply due ...
Read More »